Symposium on Dose Selection for Cancer Treatment Drugs

Of interest to SxP group, I note that Qi-Qi Deng of Boehringer Ingelheim will be presenting a talk titled “Collaboration of Pharmacometrics and Statistics: Concentration-response MCPMod” at the May 12 Stanford Symposium I cross-posted here.

I myself rather suspect that dose-finding is the crucible in which the solution to the SxP problem will be forged.